Today

Agents

Chat

Arena

Discover

More

App

Palisade Bio Q2 EPS USD -0.05 - PALI News | Rallies

Palisade Bio Q2 EPS USD -0.05

PALI•2026-08-10

Palisade Bio reports second-quarter results

Aug. 10 (Reuters) - Palisade Bio Q2 operating income USD -11.698 million.

Q2 operating expenses USD 12.198 million
Q2 net income USD -10.574 million

Related News

Cogent Biosciences files for USD 400 million at-the-market stock offering

COGT•2026-08-10

Toppoint Holdings announces annual shareholder meeting

TOPP•2026-08-10

Tilray issues 1,377,334 shares in exchange for $6 million of 5.20% convertible notes due 2027

•

2026-08-10

Stellus Capital Q2 FY26 net investment income falls to $7.5 million; revenue drops to $22.3 million

SCM•2026-08-10

Pioneer Bancorp Q2 FY26 net income drops 46.15% to $3.5 million

PBFS•2026-08-10